Fred Grossman - Jan 31, 2024 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Medical Officer
Signature
/s/ David Snyder, Attorney-in-Fact
Stock symbol
COYA
Transactions as of
Jan 31, 2024
Transactions value $
$0
Form type
4
Date filed
2/2/2024, 08:00 PM
Previous filing
Jul 19, 2023
Next filing
Jun 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +81.8K $0.00 81.8K Jan 31, 2024 Common Stock, par value $0.0001 per share 81.8K $5.90 Direct F1
transaction COYA Stock Option (right to buy) Award $0 +74.1K $0.00 74.1K Jan 31, 2024 Common Stock, par value $0.0001 per share 74.1K $5.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date.
F2 The option will vest as to 24,689 shares on July 11, 2024, with the remaining shares vesting in 24 equal monthly installments.